OTFs are well established as an important non-invasive route for drug administration. Placed on or under the tongue or buccally, they are absorbed by the oral mucosa with the active substance directly transported into the bloodstream.
It is only in true market leader organisations that pure innovation is encouraged, with experts devoting time to genuine research alongside their operational responsibilities.
LTS Lohmann Therapie-Systeme AG has once again been named a Best Managed Company, marking the third consecutive year the company has received this prestigious recognition.
Because nasal sprays are defined as combination products, it can [...]
LTS has joined the Responsible Care® Initiative of the International Council of Chemical Associations (ICCA).
LTS announced the expansion of its service portfolio to include CDMO services for ophthalmic drug delivery solutions.
LTS is a member of the UN Global Compact Network, the world’s largest initiative for sustainable and responsible corporate leadership.
In our webcast Dr. May Pidding explains how clinically needs-driven [...]
On March 5 at 13:00 CST (China) LTS, in collaboration with Ouryao, will host a live online webinar focused on development strategies and microneedle technologies for formulations target to deliver small molecules, biologics and vaccines.
Andernach and Montreal – LTS LOHMANN Therapie-Systeme AG (LTS), a [...]
